• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用桑格测序法分析胃肠道间质瘤中C-Kit外显子9、外显子11及BRAF V600E突变情况

Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours.

作者信息

Madhala Divya, Sundaram Sandhya, Chinambedudandapani MohanaPriya, Balasubramanian Archana

机构信息

Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Genetics, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

出版信息

Cureus. 2020 Mar 22;12(3):e7369. doi: 10.7759/cureus.7369.

DOI:10.7759/cureus.7369
PMID:32328381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7174865/
Abstract

Background Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms in the gastrointestinal (GI) tract. The mutation of C-KIT is considered to be the crucial step in the tumorigenesis. Targeted therapies are being developed focusing these mutations. Various exon mutations of GIST responded in varied patterns to this targeted therapy. This study was carried out to evaluate the C-KIT exon 11, exon 9 and BRAF V600E mutations among GIST specimens. Methods This retrospective study was carried out among 20 DNA extracted specimens from paraffin blocks of GIST received in our tertiary teaching institution for a period of three years. DNA sequencing was carried out for mutational analyses on C-KIT exon 9, C-KIT exon 11 and BRAF V600E genes using Sanger sequencing. Results Histologically, majority of the tumors had spindle cell morphology. About 19 cases were positive for CD117. The analysis of type of mutations showed that three cases carried Exon 11 and three cases carried Exon 9 mutations. BRAF V600E mutation was seen in one case. Conclusion It is essential to conduct molecular studies on GISTs in order to get a clear understanding of the pathogenesis and behavior pattern. This will also help in designing targeted therapies and assessing recurrence. With the advent of rapidly evolving personalized therapy, the evaluation of genetic mutations is essential for diagnosis and prognostic value.

摘要

背景 胃肠道间质瘤(GIST)是胃肠道最常见的间叶性肿瘤。C-KIT突变被认为是肿瘤发生的关键步骤。针对这些突变正在开发靶向治疗。GIST的各种外显子突变对这种靶向治疗有不同的反应模式。本研究旨在评估GIST标本中C-KIT外显子11、外显子9和BRAF V600E突变情况。方法 本回顾性研究对我们三级教学机构在三年期间接收的20例从GIST石蜡块中提取的DNA标本进行。使用桑格测序法对C-KIT外显子9、C-KIT外显子11和BRAF V600E基因进行突变分析的DNA测序。结果 组织学上,大多数肿瘤具有梭形细胞形态。约19例CD117呈阳性。突变类型分析显示,3例携带外显子11突变,3例携带外显子9突变。1例出现BRAF V600E突变。结论 对GIST进行分子研究对于清楚了解其发病机制和行为模式至关重要。这也将有助于设计靶向治疗和评估复发情况。随着快速发展的个性化治疗的出现,基因突变评估对于诊断和预后价值至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/48713cac0888/cureus-0012-00000007369-i14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/b15eaf287306/cureus-0012-00000007369-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/146cd147a460/cureus-0012-00000007369-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/058aba7bb2e0/cureus-0012-00000007369-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/5e7837b99d6f/cureus-0012-00000007369-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/a3a55d87c583/cureus-0012-00000007369-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/c5f582b428d5/cureus-0012-00000007369-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/1e13abf47e31/cureus-0012-00000007369-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/974c8a7c009f/cureus-0012-00000007369-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/2448c9e47c67/cureus-0012-00000007369-i09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/fe5156ba24dd/cureus-0012-00000007369-i10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/7835d5080e9b/cureus-0012-00000007369-i11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/21af93109b61/cureus-0012-00000007369-i12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/1b161663f1f3/cureus-0012-00000007369-i13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/48713cac0888/cureus-0012-00000007369-i14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/b15eaf287306/cureus-0012-00000007369-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/146cd147a460/cureus-0012-00000007369-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/058aba7bb2e0/cureus-0012-00000007369-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/5e7837b99d6f/cureus-0012-00000007369-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/a3a55d87c583/cureus-0012-00000007369-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/c5f582b428d5/cureus-0012-00000007369-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/1e13abf47e31/cureus-0012-00000007369-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/974c8a7c009f/cureus-0012-00000007369-i08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/2448c9e47c67/cureus-0012-00000007369-i09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/fe5156ba24dd/cureus-0012-00000007369-i10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/7835d5080e9b/cureus-0012-00000007369-i11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/21af93109b61/cureus-0012-00000007369-i12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/1b161663f1f3/cureus-0012-00000007369-i13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6d7/7174865/48713cac0888/cureus-0012-00000007369-i14.jpg

相似文献

1
Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours.采用桑格测序法分析胃肠道间质瘤中C-Kit外显子9、外显子11及BRAF V600E突变情况
Cureus. 2020 Mar 22;12(3):e7369. doi: 10.7759/cureus.7369.
2
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.V600E BRAF突变是KIT/PDGFRA野生型胃肠道间质瘤亚组中的替代性早期分子事件。
J Clin Pathol. 2009 Jul;62(7):613-6. doi: 10.1136/jcp.2009.064550.
3
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.一大组胃肠道间质瘤(GISTs)的临床病理和分子特征及文献综述:KIT/PDGFRA野生型GISTs中的BRAF突变是罕见事件。
Hum Pathol. 2017 Apr;62:206-214. doi: 10.1016/j.humpath.2017.01.005. Epub 2017 Feb 1.
4
Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.胃肠道间质瘤——原发/继发 KIT/PDGFRA 突变、BRAF 突变和 SDH 缺陷的突变状态总结。
Pathol Res Pract. 2019 Dec;215(12):152708. doi: 10.1016/j.prp.2019.152708. Epub 2019 Oct 29.
5
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.在胃肠道间质瘤中,KIT/BRAF和PDGFRA/BRAF同时发生突变是罕见事件。
Oncotarget. 2016 May 24;7(21):30109-18. doi: 10.18632/oncotarget.8768.
6
Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.胃肠道间质瘤中c-kit和PDGFR-α基因的突变与表达分析
Hepatogastroenterology. 2007 Dec;54(80):2285-90.
7
Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.KIT和PDGFRA野生型胃肠道间质瘤患者BRAF基因突变的检测
Virchows Arch. 2017 Jan;470(1):29-36. doi: 10.1007/s00428-016-2044-4. Epub 2016 Nov 18.
8
[Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].165例胃肠道间质瘤(GIST)中c-kit和PDGFRA突变的状态及临床意义
Zhonghua Bing Li Xue Za Zhi. 2006 May;35(5):262-6.
9
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.胃肠道间质瘤(GISTs)的病理学与诊断标准:综述
Eur J Cancer. 2002 Sep;38 Suppl 5:S39-51. doi: 10.1016/s0959-8049(02)80602-5.
10
The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations.非11号外显子KIT突变的晚期胃肠道间质瘤(GIST)靶向治疗的结果
Pol Przegl Chir. 2014 Jul;86(7):325-32. doi: 10.2478/pjs-2014-0057.

引用本文的文献

1
Laparoscopic resection of gastric schwannoma: a case description.腹腔镜下胃神经鞘瘤切除术:病例描述
Quant Imaging Med Surg. 2025 Feb 1;15(2):1705-1709. doi: 10.21037/qims-24-1217. Epub 2025 Jan 22.
2
Gastric schwannoma misdiagnosed as gastrointestinal stromal tumor by ultrasonography before surgery: A case report.术前超声误诊为胃肠道间质瘤的胃神经鞘瘤:一例报告
World J Clin Cases. 2022 Feb 16;10(5):1667-1674. doi: 10.12998/wjcc.v10.i5.1667.

本文引用的文献

1
Unraveling the spectrum of mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience.解析胃肠道间质瘤的突变谱:一家印度三级癌症中心的经验
South Asian J Cancer. 2017 Jul-Sep;6(3):113-117. doi: 10.4103/sajc.sajc_275_16.
2
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.BRAF V600E突变特异性免疫组化在检测BRAF V600E突变型胃肠道间质瘤中的应用
Am J Clin Pathol. 2015 Nov;144(5):782-9. doi: 10.1309/AJCPRK3V2EIIUPQZ.
3
BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance.
BRAF 突变型胃肠道间质瘤:BRAF 抑制剂达拉非尼(GSK2118436)治疗后肿瘤消退的首例报告及用于分析获得性耐药的全外显子测序
Oncotarget. 2013 Feb;4(2):310-5. doi: 10.18632/oncotarget.864.
4
Clinicopathological study of 113 gastrointestinal stromal tumors.113例胃肠道间质瘤的临床病理研究
Indian J Gastroenterol. 2013 Jan;32(1):22-7. doi: 10.1007/s12664-012-0273-2. Epub 2012 Dec 8.
5
Gastrointestinal stromal tumor: advances in diagnosis and management.胃肠道间质瘤:诊断与治疗的进展。
Arch Pathol Lab Med. 2011 Oct;135(10):1298-310. doi: 10.5858/arpa.2011-0022-RA.
6
Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).胃肠道间质瘤(GIST)中 KIT/PDGFRA/BRAF 突变和磷脂酰肌醇-3-激酶通路基因改变的谱。
Cancer Lett. 2011 Dec 15;312(1):43-54. doi: 10.1016/j.canlet.2011.07.029. Epub 2011 Aug 6.
7
Gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 121 cases.胃肠道间质瘤:121例临床病理及免疫组织化学研究
Indian J Gastroenterol. 2010 Nov;29(6):231-6. doi: 10.1007/s12664-010-0079-z. Epub 2011 Jan 11.
8
A novel primary KIT exon 9 single nucleotide substitution c.1427G>T (p.Ser476Ile) in a gastrointestinal stromal tumor.一例胃肠道间质瘤中发现一种新的原发性KIT外显子9单核苷酸替换c.1427G>T(p.Ser476Ile)
Virchows Arch. 2010 Nov;457(5):623-5. doi: 10.1007/s00428-010-0987-4. Epub 2010 Oct 5.
9
BRAF mutation status in gastrointestinal stromal tumors.胃肠道间质瘤中的 BRAF 突变状态。
Am J Clin Pathol. 2010 Jan;133(1):141-8. doi: 10.1309/AJCPPCKGA2QGBJ1R.
10
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.初治及伊马替尼耐药胃肠道间质瘤中的新型V600E BRAF突变
Genes Chromosomes Cancer. 2008 Oct;47(10):853-9. doi: 10.1002/gcc.20589.